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Abstract: Application of plasma medicine has been actively explored during last several years.
Treating every type of cancer remains a difficult task for medical personnel due to the wide variety
of cancer cell selectivity. Research in advanced plasma physics has led to the development of
different types of non-thermal plasma devices, such as plasma jets, and dielectric barrier discharges.
Non-thermal plasma generates many charged particles and reactive species when brought into contact
with biological samples. The main constituents include reactive nitrogen species, reactive oxygen
species, and plasma ultra-violets. These species can be applied to synthesize biologically important
nanomaterials or can be used with nanomaterials for various kinds of biomedical applications
to improve human health. This review reports recent updates on plasma-based synthesis of
biologically important nanomaterials and synergy of plasma with nanomaterials for various kind of
biological applications.
Keywords: plasma; nanomaterials; nanomaterial synthesis; plasma liquid Interactions; non-thermal
plasma; biomedical applications
1. Introduction
In recent years, nanomaterials have received great attention due to their exclusive characteristics
compared to their bulk counterparts. With extremely small size and high surface area, nanomaterials
demonstrate great biological activities in the human body. Nanomaterials play crucial roles in
biomedicine, with a wide range of applications such as drug delivery, cancer therapy or bioimaging.
Nevertheless, our current understanding of nanomaterials’ behaviors in human health is still
inadequate. Previous reports have claimed that nanomaterials could induce dangerous effects in
living organisms. A reasonable explanation for this concern is that conventional chemical approaches
for nanomaterial synthesis require toxic oxidants or reductants, which are essential for nanoparticle
formation and stabilization. Therefore, an alternative toxic-chemical-free synthesis is important for
nanotechnology development for biomedical applications. Currently, plasma technology is gaining
great attention as a prominent “green” synthesis method for nanomaterials, due to its distinguishing
properties when compared to solid, liquid and gas phase synthesis approaches. Furthermore,
the combination of nanomaterials and plasma in biomedical applications demonstrates several
synergistic effects and better treatment efficiency. A schematic diagram showing the synergistic
relationship among plasmas, nanomaterials and their biomedical applications is shown in Figure 1.
The use of plasmas for biomedical applications has been explored in various ways in the last few
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decades and have shown promising effects. The uses of nanomaterials in biomedical applications
are also well known. Recently, synergistic effects of nanomaterials and cold plasmas in biomedical
applications have been discovered. In this article, a review on the relationship between plasma and
nanomaterials is presented. A brief description of non-thermal atmospheric pressure plasmas is
included in Section 2. In Section 3, the synthesis of nanomaterials using different types of plasma is
summarized. Section 4 focuses on the current advances related to the synergistic effects of plasma and
nanomaterials in biomedical applications.
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2. Overview of Non-Thermal Atmospheric Pressure Plasmas and Their Characteristics
Physical plasmas are ionized gases which generally contain electrons, ions, neutrals, excited
species, electric field, reactive species, UV photons, tc. They exist aturally in the universe or can be
gen rated with n the labora ory environment in he ear h. Production of pl sma within the laboratories
can be p rformed through dissociatio of gas molecules with electrical energy confined bet een two
e ectrodes. This type of plasma can be produced at low pressur , as well as at atmosph ic pressur .
Plasmas at low pr ssures (such as inductively coupled plasmas, plasma torches) are generated inside
v cuum chamber and are much suitable for the uniform treatment of objects. They re al o called
the mal or quasi- quilibrium low-temperature plasmas, as the temperatures of light and heavy sp cies
are almost the same. At atmosp ic pressures, plasmas (such as at ospheric pres ure pl sma
jet disch rges, dielectric barrier di charges (DBD)) could be generated by ion zing a gas between
two narrow electrodes at ambient environment nd no expensive vacuum equipment is req ired.
Atmospheric pressure plasmas are also called non-therma or non-equilibrium plasmas, as the electro
t mperature is m ch higher than ions or gas species and the temperature of g s sp cies rem ins
close o oom temperat re. Both ther l and non-thermal plasmas can be used for the synthe is
of nanomaterials.
2.1. Non-Thermal Atmospheric Pressure Plasma Sources
Non-thermal atmospheric pressure plasmas generated at atmospheric conditions can be utilized
for the synt esis of nanomaterials. Several types of plasma devices, such as DBD plasma or plasma
jet, can be used for combinatio al treatments with nanomaterials [1]. The disc arge generated in
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the ambient environment can be used for the modification of the surface properties of the materials
through electrons, ions, excited species, reactive species, UVs, etc., generated through the plasma.
An overview of non-thermal atmospheric pressure plasma sources and the reactive species generated
by them is presented in this section.
2.1.1. Dielectric Barrier Discharge (DBD)
DBD is generated between two metal electrodes, where one electrode is connected to the
high voltage power supply, and the other one is grounded. A dielectric material is placed in
front of one (or both) metal electrode in order to prevent arcing. This is also known as silent or
atmospheric-pressure-glow discharge [2], and was described for the first time by Ernst Werner von
Siemens in 1857 [3]. Recent understandings of the physics of DBD have given rise to several improved
forms of DBD-based devices. A schematic diagram of two common DBD-based devices are shown in
Figure 2a,b. Both devices are constructed in a coplanar configuration, and the electrodes are fabricated
above a dielectric material like glass. A protective layer made up of MgO or Al2O3 is used above the
electrodes for the prevention of hydration and the promotion of long-term operation of the device.
If one part of the coplanar electrode system is connected to a high-voltage power supply and the
other part is grounded, it is known as surface DBD plasma (Figure 2a) [4]. Here, the material to
be treated is placed below the plasma generation region. Because of the use of coplanar electrodes
that are separated by a micrometer gap, the surface DBD plasma can be generated under normal
atmospheric conditions (even without gas flow). On the other hand, if all the coplanar electrodes are
connected to the high-voltage power supply and the target material acts as the ground electrode (with
a high capacity of charge storage) such that the plasma generated in between the high voltage and the
target is utilized for the modification of nanomaterial, it is known as floating electrode DBD plasma
(FE-DBD) [5], as schematically shown in Figure 2b. Both types of plasma sources generate plasma over
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Figure 2. Typical structures of non-thermal DB plasma and plasma jet devices at atmospheric pressure.
(a) S rface DBD plasma; (b) FE-DBD plasma; and (c) plasma jet.
2.1.2. Plasma Jet
The plasma jet is an improved design of DBD. It was designed in order to extend the plasma
plume at a long distance away from the discharge region, enabling the remote treatment of the
sample. Extensive research works have been performed on the design of plasma jets for biomedical
applications [6–8]. A schematic diagram of the plasma jet is as shown in Figure 2c. It consists of a
high-voltage needle electrode and a ground electrode separated by a dielectric material. An inert gas
flow (normally helium, argon, etc.) is maintained through the needle electrode in order to facilitate the
breakdown process. Plasma is generated between the high-voltage and the ground electrodes with
the help of working gases. Because of the high gas flow rate, the plasma constituents, including the
short-lived reactive species, are carried towards the remote region, which is several centimeters from
the discharge region. The temperature of the plasma carried to the remote region is close to room
temperature and can be used for the surface modification/synthesis of nanomaterials.
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2.2. Reactive Species Induced by Non-Thermal Atmospheric Pressure Plasmas and Their Applications
Plasma-synthesized nanomaterials can be used for various kinds of biological applications and
for improving human health. The key to this application lies in the variety of reactive oxygen and
nitrogen species (RONS) generated by the non-thermal atmospheric pressure plasma sources [9–14].
Plasma liquid interactions play a great role in the formation of nanomaterials as the chemistry of
liquid is altered by the plasma generated RONS. The major RONS formed during plasma-liquid
interactions include superoxide, hydroxyl radical, singlet oxygen, nitric oxide, ozone, hydrogen
peroxide, etc. [15,16]. The densities of these species generated in plasma discharges are very high
and have been tabulated in Table 1. Energetic electrons, heavy ions and UV photons present in the
discharge may be responsible for enhancing the formation of these reactive species.
Table 1. Typical relative concentrations of various charged and neutral species generated by
non-thermal DBD plasma in gas phase [17–20].
Plasma Generated Species Density (cm−3)
Superoxide (O2−) 1010–1012
Hydroxyl (OH•) 1015–1017
Hydrogen Peroxide (H2O2) 1014–1016
Singlet Oxygen (1O2) 1014–1016
Ozone (O3) 1015–1017
Nitric Oxide (NO) 1013–1014
Electrons (e−) 109–1011
Positive ions (M+) 1010–1012
Few reported possible reactions for plasma–liquid interactions are given in Figure 3. There are
many possibilities by which plasma-generated reactive species can have a direct or indirect effect on
nanomaterial synthesis in aqueous medium. Some can have a direct effect, and some can react to form
more stable long-lived reactive species, which can also have activity against biological samples. H2O2
is one of the most stable reactive species that can be generated from various other reactive species
such as ·OH and superoxide [21–23]. Even though ·OH has a short lifetime, our group postulates that
plasma-initiated UV may propagate into the aqua solution to result in the photolysis of water molecules
for the production of ·OH even to or inside the cells [24]. Oehmigen et al. (2011) suggested most of
the possible reactions for plasma gas/liquid interactions as shown in Figure 3. Plasma can not only
be applied for surface modification, sterilization of medical equipment, antimicrobial, dermatology
(including wound healing), etc. but also for cancer treatment by an endoscopic or branched organ
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In a recent report, Laroussi et al. demonstrated the effectiveness of a low-temperature
atmospheric-pressure plasma pencil on human T-cell leukemia cells [27]. Numerous other reports
have explored the efficiency of cold plasmas on various types of cancer and normal cell lines [28–49].
Various types of non-thermal plasmas offer the ability to deliver ROS directly or indirectly into living
tissues, implying its feasibility as an innovative device for use in cancer therapy by endoscopic or
branched organ targeting treatment technology [50–52]. Some types of plasma devices, such as DBD
plasmas or plasma jets, can be used for the combinational treatments with nanomaterials [1]. Recently,
many groups have used the plasma jet device in combination with nanomaterials for antimicrobial
and anticancer activities.
Although, a comparatively new field in medicine, the use of non-thermal atmospheric plasmas on
tumor cells has attracted a great deal of attention [53]. The outcomes of several research groups have
increased the hope that non-thermal plasmas could be an interesting new therapy alternative in cancer
treatment. Much emerging evidence strongly indicates that cold plasma treatment could abolish the
tumor cells without damaging the normal counterparts [33,54,55]. Numerous in vitro studies support
the concept of the non-thermal plasma selectivity for many types of cancer cells, including breast
cancer cells [55,56], melanoma cells [42,57], skin cancer cells [58], colon carcinoma cells [58], ovarian
cancer cells [59], glioblastoma cells [60–62], and blood cancer cells [63]. A better understanding of
biological pathways or mechanisms of plasma-mediated apoptosis, including its selectivity, will help
to introduce it as a novel tool for application in anticancer treatment as illustrated in Figure 4.
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their  unique  physical  and  chemical  properties.  Noble  metals,  transition  metals  and  alloys, 
semiconductors  and  carbon‐based  nanomaterials  are  among  the  most  prominent  materials  in 
biomedical applications,  including  cancer  therapy, bioimaging, drug delivery,  tissue engineering, 
etc.  [64–69]. Nevertheless,  the most  common  strategy  for  nanomaterials  fabrication  is  chemical 
synthesis, which involves dangerous and toxic chemical compounds as oxidizing/reducing agents. 
i r . l s s r li l s f t r tic ic f r i ic l lic ti s. r s f l s
li i l li ti , l i i itr i l i l ffects st e o ti ize .
3. Application of Plas a for the Synthesis and odification of Nano aterials
Nano aterials for bio edical applications have been receiving a great deal of attention due
to their unique physical and chemical properties. Noble metals, transition metals and alloys,
se iconductors and carbon-based nano aterials are a ong the ost pro inent aterials in
bio edical applications, including cancer therapy, bioi aging, drug delivery, tissue engineering,
etc. [64–69]. Nevertheless, the ost co on strategy for nano aterials fabrication is che ical
synthesis, hich involves dangerous and toxic che ical co pounds as oxidizing/reducing agents.
Thus, there is a need to develop alternative “green” approaches to control the toxicity of nanomaterials.
Plasma technology has been widely used in the fabrication of nanomaterials [70], especially
low-pressure techniques such as Plasma-Enhanced Chemical Vapor Deposition (PE-CVD) and
Sputtering. In contrast with low-pressure plasma, atmospheric plasma technology also can be used for
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the synthesis of nanomaterials while functioning in ambient room condition. Due to the advantages
of operating in air, atmospheric plasma can produce a high quantity of RONS, which can directly
reduce metal ions in liquid to form metal nanoparticles (NPs), without the presence of any additional
reducing agents (Figure 5). Thus, this method is also considered a “green” method for the fabrication
of nanomaterials towards applications in biomedical research. Herein, we summarize recent advances
on the fabrication of nanomaterials by plasma.
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3.1. Noble Metal Nanomaterials
Noble metals like Au, Ag, Pt and Pd possess high resistance to oxidation and corrosion in moist
conditions and have been used in jewelry and currency since ancient times. In contrast to the bulk
materials, the noble metals in nanometer size demonstrate unique physical properties, including the
surface plasmon resonance pheno enon. Surface plasmon is an evanescent electromagnetic wave
at the metal surface caused by free electron oscillation under light irradiation. Due to this property,
Au and Ag NPs have been utilized in a great number of applications, such as Surface-Enhanced
Raman Scattering, biosensors for biological processes, nanomedicine, chemical oxidation reactions, etc.
The plasma synthesis of Ag nanomaterials was first reported in 1999, through arc discharge generated
over a solution of NaNO3 with silver electrodes; one was over the solution and another was immersed
in the solution [71]. In 2005 Koo et al. reported the formation of PtNPs by exposing to H2/He gas
plasma on the solution of H2PtCl6 [72]. Since then, materials scientists have focused on the production
of NPs by using plasma over liquid system.
As pioneers in the field of plasma synthesis, Sankaran and his group attributed the Au and
Ag NP formation to the electron reduction Au and Ag ions provided by plasma either in anodic
dissolution or the pristine metal salts [73,74]. A simple microplasma setup was employed for the study,
and microplasma was generated between the surface of a liquid solution and a stainless-steel capillary
(0.7 mm distance) with the help of inert gas (helium) at a flow rate of 25 sccm. The internal diameter of
the metal capillary was less than 1 mm, and it was connected to the ground through a 100 kΩ resistor.
A high-voltage DC (up to 2 kV) was applied to a counter metal foil (Au or Ag) electrode immersed few
millimeters away from metal capillary and a current of 0–5 mA sustained the microplasma. Under the
plasma discharge, the metal dissolution occurred at the metal foils surface, followed by the formation of
metal NPs in liquid phase. Instead of metal foils, aqueous solutions of HAuCl4 or AgNO3 with different
concentrations (from 0.05 to 1 mM) can also be used as a precursor for the synthesis of Au and Ag NPs
with the same experimental setup. Electrons were injected into the liquid solution from the plasma,
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thus inducing plasma–liquid electrochemistry for the synthesis of nanomaterials [75]. The electrons
were injected in the solution and induced the reduction of Au salt, forming Au0 atoms, followed by the
diffusion and aggregation to form NPs. The gas velocity of 25 sccm supposed to limit the interaction
of the plasma with the surrounding air and study is focused on the influence of negatively charged
species. With the above experimental setup, the microplasma processing was performed for 10 min, at
which point the solution changed its color from transparent to purple, indicating the formation of Au
NPs. This was verified by Transmission Electron Microscopy and a UV-visible absorption spectrum
with resonance peak at 539 nm. The resonance peak wavelength and bandwidth depend on the size of
the Au NPs [76]. The bandwidth also depends on the distribution of Au NPs. The size and distribution
of Au NPs is usually determined by the concentration of HAuCl4 solution. The colloidal Au NPs
produced in this way were short-lived after processing. The stability can vary between 6 h and several
months, depending on several conditions, such as storage conditions, precursor concentration and
the processing current, even without using any surfactants [77]. A quantitative study for Au and
Ag NPs synthesis by microplasma was also reported recently [78]. The mechanism of dissociative
electron attachment and Au NP formation was also discussed. At the counter electrode, due to very
high applied voltage, a large number of positive ions (e.g., H+) are produced, causing a lower pH
and increased conductivity. These positive ions can participate in the overall liquid chemistry or
recombine with other species at the plasma–liquid interface. A range of species, including e−, OH•,
OH−, O−, H−, etc., are produced at the plasma–liquid interface, and they can lead to dissociative
Electron Attachment reactions (Figure 5). The most dominant reactive channel at the liquid interface is:
H2O + e−gas → H− + OH• (1)
If the electrons are solvated in liquid, the subsequent reaction inside the solution will occur:
H2O + e−aq → H− + OH• (2)
The subsequent cascaded chemistry could lead to the formation of hydrogen peroxide from either
OH• or OH− [79]. This could happen as follows:
2OH• → H2O2 (3)
2OH• → H2O2 + 2e−aq (4)
When the Au3+ ion precursor is added to the solution, the formation of Au0 metal particles in the
solution will occur as:
[AuCl4]3+ +3e−aq → Au0 + 4Cl− (5)
Recently, Mariotti et al. demonstrated a continuous droplet flow plasma reactor for the synthesis
of Au NPs. This method belongs to the most efficient and highest yielding of the reported methods
for Au NPs synthesis [80]. Plasma interactions, ionic liquids, and molten salts are also very efficient
approaches for nanomaterial synthesis. Ionic liquids possess several advantages over water solutions,
such as low vapor pressure and non-volatility. Nanoparticles synthesized using plasma-ionic liquid
systems do not require stabilizers due to their electrostatic stability. Synthesis of Au-Ag NPs by
sputtering in plasma-ionic liquid systems has been reported previously [81,82]. The selection of ionic
liquids based on low vapor pressure can facilitate highly efficient sputtering. In another reported work,
evaporation of metal ions is also used for the synthesis of some NPs [83,84]. In this experiment, a metal
wire was immersed in solution and acted as cathode while another inert Pt metal mesh used as anode.
Evaporated cathode material moved to the solution surface and cooled down, finally being quenched in
the solution, leading to formation of NPs. The amount and size of NPs depended on the applied voltage
and electrolyte solution type. A bimetallic Ag/Pt can also be produced after 30 s of pulse plasma
discharge between Ag cathode and Pt anode in solution of sodium dodecylsulfonate and sodium
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chloride. In addition to using chemical systems, physical sputtering by argon plasma was also used to
produce Au/Ag and Au/Pd NPs. Nevertheless, the main drawback of ionic liquid-based systems is
the relatively low solubility of metal ions compared to water-based systems. Another disadvantage is
that ionic liquid decomposition by plasma can contaminate the nanomaterials. The reducing species
produced by plasma moves more easily in water solution than ionic liquid. However, there are
many possibilities in the field of ionic liquids development that can address all these critical issues in
plasma-ionic liquid systems for the synthesis of nanomaterials.
3.2. Transition Metals and Alloys
The magnetic materials family is a large and compelling subject among biomedical researchers
due to the attractive super paramagnetic property. This essential property offers many opportunities
for biomedical applications, such as magnetic resonance imaging, drug delivery and biomedicine.
Plasma-based systems are being considered as cost-efficient and high-speed production methods for
metal NPs. For instance, carbon-encapsulated NPs demonstrated low toxicity on A549 cells, which
is lung fibroblast. A simple pulse discharge plasma produced between the tips of two Fe rods has
been used to synthesize the iron carbide NPs, encapsulated by graphite sheets [85,86]. Other materials,
such as Fe2O3 [87] and carbon-encapsulated Co, Ni and Fe [88,89] NPs, have been fabricated from an
aqueous solution of cationic surfactant and ethanol.
Many researchers have also studied inert material-coated iron oxide formation. Recently,
silica-coated iron oxide was formed by using non-transferred arc plasma at atmospheric pressure,
with a low degree of agglomeration [90]. In this study, there are 2 types of reactors—the hot wall
reactor and the cold wall reactor—that are used to cause variations in the temperature gradient
during the experimental period. In conclusion, silica-coated iron oxide NPs can be prepared by
using non-transferred arc plasma at atmospheric pressure with Fe(CO)5 and TEOS as the precursors.
The synthesized particles mainly have Fe3O4 as a core particle and are covered by an amorphous
external layer with a size on the order of 100 nm for cold wall reactors and below 20 nm in the case of
hot wall reactors, with uniform size distribution.
Formation of metallic oxide by plasma–liquid interactions is also a simple process because of the
presence of strong oxidizing species. An AC plasma was used to produce CuO NPs [91]. The plasma
was generated between the Cu filaments, and another Cu filament was immersed in NaNO3 solutions.
The reactive species generated by plasma–liquid interaction reduced Cu ions to form CuO NPs. ZnO
NPs can also be produced by plasma, which was generated between Zn wire and Pt wire mesh
immersed in aqueous solution of K2CO3. The median electrical power input led to the formation of
flower-like ZnO NPs.
Plasma–liquid interaction can also be used for production of alloy NPs [92,93]. Alloying of
nanomaterials is one of the strategies for stabilizing NPs. FePt NPs were synthesized by using the
displacement reaction. Argon plasma was used on FeCl2 solution to produce Fe NPs, and then PtCl2
was added to the molten solution, in which the Fe NPs were dissolved and produced. Pure FePt NPs
were obtained by optimizing the ratio of FeCl2 to PtCl2 and plasma discharge doses. The synthesis of
CoPt3, CoPt, SmCo NPs can also be carried out using the same method. A recent work by the Mariotti
group also proved that Co3O4 NPs can also be obtained by microplasma discharged in absolute
ethanol [94].
3.3. Non-Metal Nanomaterials
Silicon-based NPs have been used in biomedical applications because of their high specific surface
areas and great chemical and mechanical stability. Great efforts have been made to synthesize this
family of materials using plasma technology. In 2005, Sankaran et al. reported a continuous-flow
atmospheric-pressure microdischarge reactor for photoluminescent silicon NPs [95]. Silicon NPs
with a size of a few nanometers were successfully fabricated, and they exhibited photoluminescence
at 420 nm with an impressive quantum yield of 30%. The particles also remained stable under
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ambient conditions for several months. Surface engineering of silicon nanocrystals (Si-NCs) with
a special focus on photovoltaic applications was also studied by Mariotti et al. using microplasma
processing [96]. Si-NCs with a diameter below 5 nm exhibited quantum confinement properties
and could be applied in third-generation photovoltaic solar cells with high efficiency, low cost
and limited environmental footprint. It is believed that plasma-induced liquid chemistry offers the
opportunity for surface engineering and industrial scaling. Surface engineering of silicon nanocrystals
was performed in ethanol solution. Nickel was used as a capillary, diamond carbon rod acted as a
counter electrode, and argon gas was employed for plasma generation. After 20 min of microplasma
processing, the photoluminescence properties were observed to have improved. Also, microplasma
processing preserved the photoluminescence properties of Si-NCs for several days. These results
have not been achieved with standard electrochemistry. A detailed study of the cause of the
photoluminescence properties was performed by Fourier transform infrared analysis. This revealed
that Si-NCs under microplasma processing undergo surface modification, whereby Si-H bonds and
other surface terminations are removed and mostly replaced with Si-O-R terminations, promoting
surface reconstruction at the outer layer. Also, the efficiency of the microplasma-processed Si-NCs
device increased over the full spectral range. Recently, researchers have also made efforts to synthesize
Ge and Si quantum dots by using a plasma-ionic liquid system [97].
Carbon-related nanomaterials such as multiwall carbon nanotubes, carbon nanohorns, carbon
NPs, etc., are prominent advanced materials due to their exceptional physical properties, such
as high conductivity, strength, stiffness, and toughness. Recently, many researchers have used
plasma discharge to form carbon-related nanomaterials in liquids. Nanodiamond formation by
using microplasma operated in a gaseous phase of Ar/H2/ethanol has been reported [98]. Nowadays,
carbon nanotubes have been intensely and extensively researched, because they have very unique
and attractive physical and electrical properties, including high electrical conductivity, extraordinary
mechanical strength, and thermal and chemical stability. Therefore, it is a promising material for
versatile applications in the near future. In particular, it can be applied for optical and biomedical
devices, as well as various sensors. In a recent work, vertically aligned multi-walled carbon nanotubes
were prepared with a diameter of less than 80 nm and uniform thickness of 16 µm, by employing
microwave plasma torch with a high-speed process of only 60–120 s [99]. Carbon-encapsulated
magnetic materials were also obtained by plasma as described in the previous section [88].
Table 2 summarizes current advances of several nanomaterials synthesized by plasma
technologies. In the future, the main focus of plasma-induced synthesis of nanomaterials should
be on the improvement of several essential factors, such as controlled synthesis, oxidation prevention,
impurity and industrial scale production. More detailed studies need to implement for synthesis and
diagnostic for application of nanomaterials in biomedicine and other applications.
Table 2. Summary of nanomaterials synthesized by plasma technologies.
Materials Methods Average Size References
Ag Nanowire Arc Plasma 5–15 nm (diameter)<100 nm length [71]
Pt NPs RF Plasma 2 nm [72]
Au NPs, Ag NPs Microplasma 8 nm–10 nm [73,74,77,78]
Au NPs Microplasma 4.4 nm [80]
Au NPs Sputter 5.5 nm [81]
Au-Ag Alloy Sputter 2.6–6.0 nm [82]
Ag Nanopowder Wire explosion 20-200 nm [83]
Au, Ag, Ti, Ni Nanoball Plasma electrolysis 10 nm [84]
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Table 2. Cont.
Materials Methods Average Size References
FeC NPs Plasma in liquid ethanol 5–600 nm [85]
FeC Nanocapsule Plasma in liquid ethanol 10–20 nm [86]
Fe3O4 Pulsed Plasma in liquid 19 nm [87]
Fe NPs Pulsed Plasma in liquid 35 nm [88]
Ni NPs Pulsed Plasma in liquid 26 nm [88]
Co NPs Pulsed Plasma in liquid 20 nm [88]
Fe@C NPs Pulsed Plasma in liquid 32 nm [89]
Ni@C NPs Pulsed Plasma in liquid 40 nm [89]
Fe3O4@Si Arc Plasma 20 nm [90]
CuO nanorods Arc Plasma 14–16 nm [91]
Cu NPs Arc Plasma 30–50 nm [91]
Cu2O NPs Arc Plasma 4–10 nm [91]
FePt NPs Microplasma Less the 100 nm [92]
Co3O4 NPs Microplasma 2–5 nm [94]
Si NPs Microplasma 1–3 nm [95]
Nanodiamond Microplasma 3 nm [98]
Multiwalled-Carbon Nanotubes Microwave Plasma 80 nm (diameter) [99]
4. Plasma and Nanomaterial Combination Treatment on Cells and Microbes
Non-thermal plasma can directly or indirectly kill cancer cells. Use of conjugated or un-conjugated
NPs can increase the specificity and efficiency of treatment. There are many reports in which researchers
use antibody-conjugated NPs to enhance cell death and reduce the cell viability of cancer cells. In future,
this combination technology could become a feasible therapeutic technology against various kinds of
cancers or tumors.
In cancer treatment, it is very important to induce cell death specifically in cancer tissue or mass.
However, plasma cannot efficiently distinguish between normal and cancer tissue. Recently, researchers
used Au NPs (which are harmless to the human body at low doses) conjugated with antibody (which
targets overexpressed proteins on or in cancer cells). Choi et al. used Au NPs conjugated with antibody
against epidermal growth receptor (EGFR) [45]. EGFR protein is overexposed in many types of cancer
cells, more specifically in oral cancer cells. They used low doses of air plasma (9.2 J/cm2 for 30 s) with
anti-EGFR antibody-conjugated Au NPs to selectively kill oral cancer cells. Morphology was changed
from a spindle shape to a round shape, cell shrinkage and membrane rupture were observed in oral
cancer cells treated with plasma plus conjugated Au NPs. However, the whole mechanism for this
combination treatment is still not known, and has to be elucidated in the future.
The research group of Prof Michael Keider and Jonathan H. Sherman demonstrated the synergistic
effect of Au NPs and cold plasma on glioblastoma (brain cancer) cancer cells [100]. They revealed that
the synergistic effect between Au NPs and atmospheric pressure cold plasma is dependent on the
concentration of Au NPs. Au NPs significantly increase cell death by 30% in glioblastoma cell line
with the same plasma dosage. They concluded that intracellular reactive oxygen species accumulation
results in the oxidative stress, which further changes the intracellular pathways, and also increases
damage to protein, DNA and lipid molecules. These studies showed that synergy has great potential
to improve cancer therapy and reduce the harm to normal cells.
Researchers also targeted NEU (human epidermal growth factor receptor 2) protein, which is
frequently overexpressed on the cell membrane of skin cancer (melanoma) cells. They used anti-NEU
antibody-conjugated Au NPs in this recent study. These nanoparticles were selectively uptaken by
skin cancer cells rather than normal keratinocyte. Both cancers, as well as normal cells, were treated by
non-thermal atmospheric pressure plasma after the addition of conjugated Au NPs. This combination
treatment selectively enhanced the death rate of skin cancer cells significantly rather than normal
keratinocyte cells. This selective skin cancer cell death is may be due to selective destruction of NEU
protein and a downstream effect of NEU [101].
Nanomaterials 2019, 9, 98 11 of 19
Recently, non-thermal atmospheric pressure plasma with Au NPs was also used for killing
microbes. Non-thermal plasma efficiently kills oral bacteria on agar plates; however, it has less effect
on the tooth surface. Therefore, researchers used 30-nm Au NPs to enhance the killing effect of
non-thermal on oral bacteria (Streptococcus mutans) on the tooth. Non-thermal plasma treatment alone
decreased viability by 5 log of S. mutans in vitro; however, plasma treatment of bacteria on tooth
surface exhibited only a 3-log reduction in viability. When they added Au NPs to the bacteria, plasma
treatment also showed a 5-log reduction in the viability of bacteria, while Au NPs alone did not show
any antibacterial effect. The morphological examination by transmission electron microscopy showed
that plasma treatment only perforated the bacterial cell walls; however, combination treatment with
plasma and Au NPs caused significant cell damage, causing loss of intracellular components from
many bacterial cells [102].
Our group has also reported the synergistic effect of PEG-coated Au NPs (PEG-Au NPs) and
non-thermal plasma on epithelial-mesenchymal transition (EMT) and the maintenance of cancer stem
cells (CSC) on solid cancer cells. The results showed that co-treatment with PEG-GNP and non-thermal
plasma inhibited growth in cancer cells by altering the PI3K/AKT signaling axis. This non-thermal
plasma and PEG-Au NP co-treatment reversed EMT in tumor cells by altering signaling proteins,
resulting in the upregulation of epithelial markers such as E-cadherin and down-regulation of
N-Cadherin, Slug and Zeb-1. It was also shown that this co-treatment also inhibited tumor growth by
decreasing mesenchymal markers in tumor xenograft mice models. This kind of combination treatment
also inhibited sphere formation and the self-renewal capacity of glioma-like stem cells [103,104].
In another recent report, the synergistic cytotoxicity of Au NPs and non-thermal plasma showed
enhanced endocytosis and trafficking to the lysosomal compartment as well as temporarily increased
membrane permeability. This report contributes knowledge to the mechanism of combination effects
of non-thermal plasma and NPs and indicates a technology for possible drug delivery systems. It is
demonstrated that the rates of Au NPs uptake and total amount accumulated in solid cancer cells
are significantly enhanced after exposure to 75 kV non-thermal plasma generated by DBD. Chemical
effects induced by direct and indirect exposure to non-thermal plasma appear the dominant mediator
of enhanced uptake [105]. They also showed that Au NPs and non-thermal co-treatment caused
many divots across the glioma cell membrane, making it more porous. In contrast, there was no
significant effect or NP uptake in astrocyte (E6/E7) cells, and there was no change in the cell membrane
morphology. These studies prove that plasma-based nano-drug delivery technology is safe and
effective against solid tumors [106].
To maximize the preferential killing of melanoma cells non-thermal plasma is used with Au NPs
tagged with antibodies targeting phosphorylated FAK (p-FAK). Combined treatment also showed the
minimum effect against HaCaT keratinocyte cells. After co-treatment on melanoma cells, signaling
molecules such as FAK, p-paxillin, and NEU were reduced with treatment. Therefore, it is suggested
that these kinds of co-treatment strategies are effective and selective against melanomas [107]. Recently
core-shell NPs were synthesized via co-axial electrospraying. Biocompatible poly (lactic-co-glycolic
acid) was used as the polymer shell to encapsulate anti-cancer treatment. In vitro studies demonstrated
the synergistic effect of these core-shell NPs and non-thermal plasma for inhibition of breast cancer
cell growth when compared to each treatment alone. Non-thermal plasma induced down-regulation
of metastasis-related gene expression (VEGF, MTDH, MMP9, and MMP2) and facilitated drug-loaded
nanoparticle uptake, which could be an important breakthrough minimizing drug resistance, a major
problem in cancer chemotherapy [108].
Iron NPs 50 nm in size were also used for combination treatment with non-thermal plasma
against human breast adenocarcinoma cells. Findings showed that the combination of plasma and
iron NPs inhibited the viability of cancer cells significantly. Molecular analysis demonstrated that
the combination treatment induced shifting the BAX/BCL-2 ratio in favor of apoptosis [109]. Table 3
summarizes recent updates on plasma and nanomaterials combination for cancer treatment.
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Table 3. Recent updates on plasma and nanomaterial combination treatment against cancers.
Published Year Cancer Type Plasma Device Nanomaterial Reference
2014 Glioblastoma Plasma jet Au NPs [100]
2015 Melanoma Surface type air plasma Anti-NEU-Au NPs [101]
2017, 2016 Glioblastoma Surface DBD air plasma PEG-Au NPs [103,104]
2018 Glioblastoma DBD plasma Au NPs [105]
2015 Glioblastoma Plasma jet Au NPs [106]
2017, 2009 Melanoma DBD Plasma Anti-FAK-Au NPs [35,107]
2016 Breast Cancer Cold atmospheric plasma Fluorouracil loaded core-shell NPs [108]
2016 Breast Cancer Plasma jet Iron NPs [109]
2015 Colorectal Cancer Plasma jet Au NPs [110]
2017 Lung Cancer DBD plasma Epidermal growth factor conjugatedAu NPs [111]
In addition, cold plasmas are widely used as treatment tools for biomaterial surfaces, such as
polymers, metals, alloys, ceramics, and composites [112]. The plasma treatment is capable to activate
or functionalize the material surfaces and also produces several exclusive properties compared to other
chemical and physical methods. Due to the low penetration capability, plasma can only be able to
modify very few thin layers of the surface with a thickness of a hundred nanometers. Thus, the surface
properties can be altered, in order to enhance the biocompatibility and bio-functionalization, which are
vital parameters towards practical applications of synthetic biomaterials. In general, plasma-modified
biomaterials possess great potential for the applications in dentistry, tissue engineering or drug delivery.
For instance, metal NPs with antimicrobial or bactericide properties can be incorporated or coated on
the surfaces of implants by plasma modification techniques. Plasma treatment also can change the
surface roughness and increase the hydrophilicity of biodegradable polymers, thus improve the cell
affinity and cell adhesion of these materials. Moreover, plasma surface modification can promote the
attachment, loading, and release of drug molecules in porous biomaterials.
Recently, Rosales et al. have reported the effect of plasma surface modification on antibacterial
properties of Cu NPs [113]. The surface of Cu NPs was functionalized with polyacrylic acid,
polyacrylonitrile, or polymethyl methacrylate by utilizing the radiofrequency plasma reactor to
enhance the biocompatibility. During the plasma polymerization, the simultaneous removal of CuO
upper layers on the surface of Cu NPs was observed. The polymer layers also acted as protecting
layers, preventing Cu NPs being oxidized. The coating polymer films on Cu NPs were thin enough
for the copper ions to easily diffuse through the coating layer and subsequently interact with bacteria.
The antibacterial properties of the Cu NPs were not significantly affected by the plasma modification.
They demonstrated outstanding antibacterial property against Gram-positive bacteria (P. aeruginosa).
The plasma polymerization-coated Cu NPs also possessed significantly lower toxicity to normal human
cells as compared to pristine copper NPs.
Titanium biomaterials are frequently used in medical and dental sciences. Titanium dental
implants have promising potentials as the replacements of missing teeth. However, there are chances
of failure in dental implants after surgeries in extraction sockets. Atmospheric pressure plasma
treatment can be used to soft tissue around titanium dental implant abutments surface without
causing topological changes. The topology and chemistry of titanium implants are important factors
for osseointegration. A preliminary research work in this field studied the cellular attachment and
differentiation of titanium nanotubes treated by air or nitrogen non-thermal atmospheric pressure
plasma jets [114]. After plasma treatment the ostogenic properties were improved without any
change in topographical morphology. In addition, plasma treatment of nanotubes further increased
hydrophilicity, as well as modifying the surfaces. It was demonstrated that cellular activity and in vitro
osseointegration were significantly enhanced on plasma-treated titanium nanotube.
Another example is Poly(lactide-co-glycolide) or PLGA NPs, which can be applied for sustained
delivery of proteins for nervous tissue repair. However, sterilization of protein-loaded PLGA is a
challenging task, due to the possibility of reducing the activity of proteins. Recently, researchers
from Drexel University reported sterilization of protein-loaded PLGA NPs by using indirect plasma
Nanomaterials 2019, 9, 98 13 of 19
treatment [115]. They used plasma-treated water and PBS for sterilization of NPs and proteins.
Plasma-treated water showed no morphological changes to the NPs. They concluded that treatment of
particles in plasma-treated PBS is effective for decontaminating particles, as well as in maintaining
protein activity; thus, is possible to apply it for nervous tissue repair therapy.
5. Summary and Future Prospectives
Great efforts have been carried out over the last few decades focusing on the synergistic effects of
non-thermal plasma and nanomaterials towards applications in biomedical science. The combination
of these two emerging research fields typically refers to two different strategies. The first is the synthesis
of nanomaterials using non-thermal plasma, which has been proved as a simple, effective, low-cost and,
furthermore, clean method. It can eliminate the consumption of toxic chemical components during
the fabrication of nanomaterials, which are typically used in other conventional methods, such as
chemical and physical synthesis technologies. Thus, the toxicity of plasma-synthesized nanomaterials
is relatively lower, making them become more appropriate for biomedical practical applications.
Depending on the structures of the nanomaterials, the RONS induced by plasma can be encapsulated
inside the materials; hence, their live-time and travel distance will increase. These two parameters
are vital problems that non-thermal plasma technology has been dealing with, in order to enhance
effectiveness. The second is the combination of plasma and post-synthesized nanomaterials. Under
non-thermal plasma treatment, the cell membranes can be open or enlarged, therefore increasing
the cell permeation. Consequently, nanomaterials can easily penetrate through cell membranes.
In addition, the low selectivity property of non-thermal plasma can be compensated by nanomaterials,
which are generally functionalized for specific targets.
This review briefly summarizes recent progress in the combination of plasma and nanomaterials.
Important challenges remain for the utilization of this interdisciplinary field in the future.
The understanding of plasma and nanomaterials interactions, in both synthesis and post-synthesis are
still inadequate. Due to the presence of a variety of species, electric field and radiation, non-equilibrium
chemistry processes between plasma and nanomaterials are exceptionally complex and difficult to
control. The homogeneity of the desired nanostructures by plasma synthesis is limited, compared to
other methods. Thus, further studies are required to understand the natures and extending the use of
plasma and nanomaterials combination, not only limited to biomedical, but also many other biological
applications. In addition, plasma-assisted nano-drug delivery systems are potential subjects for future
biomedical researches. This advanced technology can be utilized in clinical and aesthetic purposes.
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UV ultra-violet
DBD dielectric barrier discharge
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